Cassava Sciences Inc SAVA Fundamentals and Key Ratios

Cassava Sciences Inc. (SAVA) Fundamentals


Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms.

SHARE INFORMATION
Market Cap	$ 1,315,504,757
Shares Outstanding	41,735,557
Float	39,486,375
Percent Float	94.61%
Short Interest	0.00
Short Percent Float	0.0%
Short Interest Ratio	0.00
Short Interest Date	-
Latest Fiscal Dividend Per Share	$ 0.00
Latest Fiscal Revenue	$ 0
Latest Fiscal EPS	$ -0.82
Latest Fiscal Date	2021-12-31

DIVIDENDS
Dividend (3 Years)	$ 0.00
Dividend (5 Years)	$ 0.00
Ex Dividend Date	-
Dividend Rate	$ 0.00
Dividend Yield	0.0%
Payment Cash	Cash

HOLDERS
Institutions	325
Institutional Holdings Date	2023-01-31
Institutional Bought Previous 3 Months	1,070,657
Institutional Holdings Percent	49.7%
Institutional Sold Previous 3 Months	838,953
Insider Holdings Date	2022-12-31
Insider Bought Previous 3 Months	109,376
Insider Holdings Percent	5.1
Insider Sold Previous 3 Months	9,376
Insider Shares Owned	2,110,804

TRADING INFO
52 Week High	$ 62.49
52 Week Low	$ 13.84
52 Week High Change	$ -31.07
21 Day Moving Average	$ 31.131
21 Day Extended Moving Average	$ 30.9816
50 Day Moving Average	$ 33.4298
50 Day Extended Moving Average	$ 32.5583
200 Day Moving Average	$ 29.5864
200 Day Extended Moving Average	$ 33.7985
10 Day Average Volume	2,983,835
20 Day Average Volume	2,088,902
30 Day Average Volume	1,820,256
50 Day Average Volume	1,536,544
Alpha	0.145935
Beta	-0.0843
Standard Deviation	0.628646
R2	0.000052
7 Day Price Change	$ 3.61
7 Day Percent Change	12.93%
21 Day Price Change	$ -2.54
21 Day Percent Change	-7.46%
30 Day Price Change	$ 1.98
30 Day Percent Change	6.7%
Month to Date Price Change	$ 3.52
Month to Date Percent Change	12.57%
Quarter to Date Price Change	$ 1.98
Quarter to Date Percent Change	6.7%
180 Day Price Change	$ 12.14
180 Day Percent Change	62.64%
200 Day Price Change	$ 7.61
200 Day Percent Change	31.83%
Year to Date Price Change	$ 1.98
Year to Date Percent Change	6.7%

PROFITABILITY
EBIT Margin	0.0%
EBITDA Margin	0.0%
Pre-Tax Profit Margin	0.0%
Profit Margin Count	0.0%
Gross Margin	0.0%
Profit Margin TOT	0.0%

INCOME STATEMENTS
Revenue	$ 0
Revenue Per Share	$ 0.00
Revenue (3 Years)	$ 0.00
Revenue (5 Years)	$ 0.00

FINANCIAL STRENGTH
Price to Tangible Book	6.10
Total Debt To Equity	0.00
Int Coverage	0.00
Current Ratio	22.10
Leverage Ratio	1.00
Quick Ratio	21.00
Long Term Debt To Capital	0.00

VALUATION MEASURES
PE Ratio	-16.10
Enterprise Value	$ 1,027,486,041
Price to Sales	0.00
Price to Free Cash	-20.30
PE High Last 5 Years	-4.00
Price To Book	6.10
Price To Cash Flow	0.00
PE Low Last 5 Years	-26.90
Price to Tangible Book	6.10

MANAGEMENT EFFECTIVENESS
Receivables Turnover	0.00
Invoice Turnover	0.00
Assets Turnover	0.00
Return Assets	-29.61
Return on Equity	-30.58
Return on Capital	-31.08

PROFILE INFO
Issue Type	CS
SEC Type	EQS
Auditor	Ernst & Young LLP
CEO	Remi Barbier
Emplyoees	24
Last Audit	UQ
CIK	0001069530
Industry	Biotechnology
Sector	Healthcare
NAICS	Pharmaceutical Preparation Manufacturing(325412)

CONTACT INFO
Address	7801 N. Capital of Texas Highway Suite 260 Austin, TX 78731
Website	https://www.cassavasciences.com
Facsimile	+1 512 501-0414
Telephone	+1 512 501-2444
Email	IR@cassavasciences.com

Quotes:

IHub:

SAVA

Cassava Sciences Inc. (SAVA) Fundamentals

Cassava Sciences Inc. (SAVA) Key Ratios

Cassava Sciences Inc. (SAVA) Profile